Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes have?

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes has 67 citations in the OpenAlex counts ScholarIQ stores.

When was Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes published?

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes has 2019 year in the ScholarIQ index.

What is the open-access status of Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes has closed oa status in the ScholarIQ index.

What is the DOI of Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?

The DOI for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is on the source record.

What is the PMID of Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?

The PMID for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is on the source record.

What is the OpenAlex record for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?

The OpenAlex for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is on the source record.